Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn ... Read More
-
Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review
Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn ... Read More
-
Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review
Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak ... Read More
-
Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review
Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne ... Read More
-
Q1 2025 CRO Activity and Intel Report
Q1 2025 CRO Activity and Intel Report Summary This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q1 2025. Scope The Q1 CRO Activity and Intel report offers insights into CRO and sponso ... Read More
-
Opportunities in the Global OTC Healthcare Sector 2025
Opportunities in the Global OTC Healthcare Sector 2025 Summary The global OTC healthcare sector was valued at $178.7 billion in 2024 and will reach $202.7 billion in 2029 at a compound annual growth rate (CAGR) of 2.6%. In 2024, traditional medicines was the largest category by value, accounting for ... Read More
-
New US Administration: Looming Tariffs on Pharma Timelines
New US Administration: Looming Tariffs on Pharma Timelines Summary Within the first 100 days of the current US Administration, there has been a clear shift toward more protectionist trade policy. The 47th US President has implemented a series of tariff measures aimed at reducing the trade deficit. T ... Read More
-
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry Summary Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry. To date, key outcomes have included - Leadership cha ... Read More
-
Looking Ahead to 2025 - the Future of Pharma
Looking Ahead to 2025 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
Bio/Pharmaceutical Outsourcing Report, March 2025
Bio/Pharmaceutical Outsourcing Report, March 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing co ... Read More
-
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC) Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases There are currently ten actionable genomic alterations (AGAs) that are addressed by ... Read More
-
Biosimilars - Through the Physician’s Lens
Biosimilars - Through the Physician’s Lens Summary Since their introduction within the past few decades, biosimilars outrivaled biologics in reducing treatment costs and improving access to therapies for chronic conditions such as cancer, rheumatoid arthritis (RA), and diabetes. Nevertheless, while ... Read More
-
Pulmonary Fibrosis - Global Clinical Trials Review, 2025
Pulmonary Fibrosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Pulmonary Fibrosis - Global Clinical Trials Review, 2025 provides an overview of Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pu ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025
Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025 provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report pro ... Read More
-
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025 provides an overview of Squamous Non-Small Cell Lung Cancer Clinical trials scenario. This report provides ... Read More
-
Meningitis - Global Clinical Trials Review, 2025
Meningitis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Meningitis - Global Clinical Trials Review, 2025 provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report include ... Read More
-
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 provides an overview of Actinic (Solar) Keratosis Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 provides an overview of Acute Decompensated Heart Failure Clinical trials scenario. This report provides top li ... Read More
-
Tuberculosis - Global Clinical Trials Review, 2025
Tuberculosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Tuberculosis - Global Clinical Trials Review, 2025 provides an overview of Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review
RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo ... Read More
-
Malaria - Global Clinical Trials Review, 2025
Malaria - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2025 provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overvie ... Read More
-
Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025
Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025 provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario. This report provides ... Read More
-
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 provides an overview of Erythrodermic Psoriasis Clinical trials scenario. This report provides top line data relating to the clinic ... Read More
Research Assistance
